AdipoGen Life Sciences’ anti-ACE2 (human), mAb (AC18F) is a monoclonal antibody clone that recognises human ACE2 and works in Flow Cytometry (FACS).
Flow Cytometry-Competent Human ACE2 Monoclonal Antibodies


AdipoGen Life Sciences’ anti-ACE2 (human), mAb (AC18F) is a monoclonal antibody clone that recognises human ACE2 and works in Flow Cytometry (FACS).
To support the efforts of researchers worldwide in understanding and combating SARS-CoV-2, ProSci Inc has developed and manufactured COVID-19 (SARS-CoV-2, 2019-nCoV) antibodies and research reagents against the virus, and virus receptor ACE2. Polyclonal antibodies and monoclonal antibodies are available against
Coronavirus 19 is known to infect the respiratory tract and cause mild or highly acute respiratory syndrome. A consequence of this is the release of pro-inflammatory cytokines, including interleukin (IL)-1β and IL-6 (1). This hyperinflammatory response is thought to be
The Diaclone name has stood for quality and reliability for 34 years. Based in Besançon, France, Diaclone pride themselves on excellence in monoclonal antibody and immunoassay development and manufacture. The expanding range of Diaclone immunology products is specifically designed to
Understanding binding affinity is an important part of the drug discovery process, ensuring that therapeutic antibodies that bind their targets selectively and specifically. It also helps to understand the intermolecular interactions driving biological processes, structural biology, and structure-function relationships. KD
![Recombinant Monoclonal Antibodies [RecMAbs™] – Produced with No Use of Animals Recombinant Monoclonal Antibodies [RecMAbs™] – Produced with No Use of Animals](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/Adipogen-logo-600x300.png)
Antibody phage display is an in vitro technology to generate recombinant monoclonal antibodies (RecMAbs™) without the use of animals.

A committee, including Adipogen, made guidelines for antibody validation & detailed context-dependent measures to be followed by antibody suppliers.

Single Domain Antibodies (aka Nanobodies, VHH antibodies & camelid antibodies) are at the forefront of research in HIV, cancer, & other cell diseases.
The single-domain antibodies (sdAb), lack light chains, yet possess unique characteristics providing researchers a myriad of options not readily available with conventional antibodies. In comparison, the sdAbs boast significantly higher stability and are much smaller in size, only 15kd. As
Neuromics’ continually add new antibodies to their portfolio to further aid in scientific research. Many of the new additions are part of their frequently used and widely published Neuron-Glial Markers. All Neuromics’ products are tested, characterized and research ready.